MDC Acquires Lighteum: Expansion and Innovation in Medical Components

Deal News | Nov 11, 2024 | Montagu Private Equity

MDC Acquires Lighteum: Expansion and Innovation in Medical Components

MDC (Medical Device Components), an eminent figure in the domain of precision, minimally invasive medical device components, recently completed the acquisition of Lighteum, a specialist in nitinol-based medical component manufacturing. The deal was finalized on November 8, 2024. This acquisition signifies MDC's commitment to innovation by merging its extensive experience in platinum group metals and advanced micromachining with Lighteum's proficiency in nitinol process technology, which includes high-throughput laser cutting and electropolishing. This strategic integration aims to enhance MDC's capacity to offer a wider range of services and align with the burgeoning demands of the medical device industry. Montagu Private Equity, having recently supported the carve-out of MDC, expresses optimism about the expanded design and development capabilities brought by Lighteum. This combined effort aims to accelerate the introduction of life-saving medical technologies to the global market. With expanded operations and continued customer-centric strategies, MDC and Lighteum envisage pushing the boundaries of medical device manufacturing.

Sectors

  • Medical Device Manufacturing
  • Private Equity

Geography

  • Global – MDC and Lighteum operate on a global scale, with expanded manufacturing capabilities in San Diego, Mexicali, Australia, and other locations worldwide.

Industry

  • Medical Device Manufacturing – The article primarily focuses on the acquisition within the medical device components sector, highlighting the manufacturing and technological capabilities of MDC and Lighteum.
  • Private Equity – The involvement of Montagu Private Equity in supporting MDC's acquisition of Lighteum underscores this industry's relevance in the transaction.

Financials

  • Not disclosed – The financial terms of the acquisition have not been disclosed.

Participants

NameRoleTypeDescription
MDCAcquirerCompanyA global leader in the development and manufacture of precision medical components, specializing in platinum group metals and nitinol.
LighteumTarget CompanyCompanyA manufacturer specializing in high-complexity nitinol-based medical components.
Montagu Private EquityPrivate Equity FirmCompanySupported MDC's acquisition of Lighteum following its carve-out.
Covington AssociatesFinancial AdvisorCompanyServed as exclusive financial advisor to Lighteum during the transaction.
Don FreemanCEOPeopleCEO of MDC overseeing the acquisition.
Adrien SassiPartnerPeoplePartner at Montagu Private Equity, expressing support for the acquisition.
Lorie Lodico IVCOOPeopleCOO of Lighteum, discussing the benefits of joining MDC.
Jose MaesoCTOPeopleCTO of Lighteum, emphasizing the technological synergies from the acquisition.